Ashburton (Jersey) LTD Abb Vie Inc. Transaction History

Ashburton (Jersey) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Apr 26, 2023	SELL	$134.21 - $153.93 $29,928 - $34,326	-223 Closed	0 $0
Q4 2020 May 23, 2023	BUY	$80.49 - $108.67 $17,949 - $24,233	223 New	223 $24,000
Q2 2020 Aug 06, 2020	SELL	$73.37 - $98.18 $59,796 - $80,016	-815 Reduced 78.52%	223 $22,000
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $4,472 - $5,595	-62 Reduced 5.64%	1,038 $92,000
Q2 2019 Jul 26, 2019	BUY	$65.7 - $83.98 $72,270 - $92,378	1,100 New	1,100 $80,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Ashburton (Jersey) LTD, based on Form 13F filings with the SEC.

Stay updated on Ashburton (Jersey) LTD with notifications on news.